Cargando…

Modelling Diabetic Cardiomyopathy: Using Human Stem Cell-Derived Cardiomyocytes to Complement Animal Models

Diabetes is a global epidemic, with cardiovascular disease being the leading cause of death in diabetic patients. There is a pressing need for an in vitro model to aid understanding of the mechanisms driving diabetic heart disease, and to provide an accurate, reliable tool for drug testing. Human in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Purnama, Ujang, Castro-Guarda, Marcos, Sahoo, Om Saswat, Carr, Carolyn A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503602/ https://www.ncbi.nlm.nih.gov/pubmed/36144236 http://dx.doi.org/10.3390/metabo12090832

Ejemplares similares

Physiological and pharmacological stimulation for in vitro maturation of substrate metabolism in human induced pluripotent stem cell-derived cardiomyocytes
por: Lopez, Colleen A., et al.
Publicado: (2021)

Activation of HIF1α Rescues the Hypoxic Response and Reverses Metabolic Dysfunction in the Diabetic Heart
por: Sousa Fialho, Maria da Luz, et al.
Publicado: (2021)

Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies
por: Brodehl, Andreas, et al.
Publicado: (2019)

Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging Models
por: Granéli, Cecilia, et al.
Publicado: (2018)

Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy
por: Knight, Walter E., et al.
Publicado: (2021)

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
por: Li, Jiangtao, et al.
Publicado: (2022)

Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients’ Induced Pluripotent Stem-Cell-Derived Cardiomyocytes
por: Eisen, Binyamin, et al.
Publicado: (2023)

Disease modeling of desmosome-related cardiomyopathy using induced pluripotent stem cell-derived cardiomyocytes
por: Higo, Shuichiro
Publicado: (2023)

Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes
por: De Bortoli, Marzia, et al.
Publicado: (2023)

Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
por: Silva dos Santos, Danúbia, et al.
Publicado: (2018)

A Network Pharmacology Study of the Multi-Targeting Profile of an Antiarrhythmic Chinese Medicine Xin Su Ning
por: Wang, Taiyi, et al.
Publicado: (2019)

Human-Induced Pluripotent Stem Cell–Derived Cardiomyocyte Model for TNNT2 Δ160E-Induced Cardiomyopathy
por: Kondo, Takumi, et al.
Publicado: (2022)

Application of Animal Models in Diabetic Cardiomyopathy
por: Lee, Wang-Soo, et al.
Publicado: (2021)

Metabolic flux analyses to assess the differentiation of adult cardiac progenitors after fatty acid supplementation
por: Malandraki-Miller, Sophia, et al.
Publicado: (2019)

Cardiomyocyte Regeneration in the mdx Mouse Model of Nonischemic Cardiomyopathy
por: Richardson, Gavin David, et al.
Publicado: (2015)

Circular RNA Expression for Dilated Cardiomyopathy in Hearts and Pluripotent Stem Cell–Derived Cardiomyocytes
por: Zhang, Yiyu, et al.
Publicado: (2021)

Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes
por: Ovchinnikova, Ekaterina, et al.
Publicado: (2018)

Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
por: Eschenhagen, Thomas, et al.
Publicado: (2018)

Modeling Cardiomyopathies in a Dish: State-of-the-Art and Novel Perspectives on hiPSC-Derived Cardiomyocytes Maturation
por: Lodola, Francesco, et al.
Publicado: (2021)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
por: Hoekstra, Maaike, et al.
Publicado: (2012)

Investigating LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Shemer, Yuval, et al.
Publicado: (2021)

Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
por: Miyagawa, Shigeru, et al.
Publicado: (2022)

Genetic Animal Models for Arrhythmogenic Cardiomyopathy
por: Gerull, Brenda, et al.
Publicado: (2020)

Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte
por: Filardi, Tiziana, et al.
Publicado: (2019)

Mathematical modelling of the action potential of human embryonic stem cell derived cardiomyocytes
por: Paci, Michelangelo, et al.
Publicado: (2012)

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
por: Maillet, Agnes, et al.
Publicado: (2016)

Cardiomyocyte Dysfunction in Inherited Cardiomyopathies
por: Hassoun, Roua, et al.
Publicado: (2021)

Mogroside IIe Ameliorates Cardiomyopathy by Suppressing Cardiomyocyte Apoptosis in a Type 2 Diabetic Model
por: Cai, Xin, et al.
Publicado: (2021)

Zika virus-induces metabolic alterations in fetal neuronal progenitors that could influence in neurodevelopment during early pregnancy
por: Gilbert-Jaramillo, Javier, et al.
Publicado: (2023)

Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
por: Brasil, Guilherme Visconde, et al.
Publicado: (2020)

Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy
por: Prajapati, Chandra, et al.
Publicado: (2018)

Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes
por: Kumar, Satish, et al.
Publicado: (2021)

Cardiomyocyte apoptosis contributes to contractile dysfunction in stem cell model of MYH7 E848G hypertrophic cardiomyopathy
por: Loiben, Alexander M., et al.
Publicado: (2023)

Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of MYH7 E848G Hypertrophic Cardiomyopathy
por: Loiben, Alexander M., et al.
Publicado: (2023)

The metabolic addiction of cancer stem cells
por: Sahoo, Om Saswat, et al.
Publicado: (2022)

Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening
por: Sharma, Arun, et al.
Publicado: (2013)

Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes
por: Hulot, Jean-Sébastien, et al.
Publicado: (2014)

Coupling primary and stem cell–derived cardiomyocytes in an in vitro model of cardiac cell therapy
por: Aratyn-Schaus, Yvonne, et al.
Publicado: (2016)

Coupling primary and stem cell–derived cardiomyocytes in an in vitro model of cardiac cell therapy
por: Aratyn-Schaus, Yvonne, et al.
Publicado: (2016)

Modelling cadmium‐induced cardiotoxicity using human pluripotent stem cell‐derived cardiomyocytes
por: Shen, Jiaxi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c0vj6qeh21ij3kdmhbgsqplf2v